Wrap Technologies (WRAP) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
13 May, 2026Executive summary
Revenue grew 45% year-over-year to $1.1 million in Q1 2026, driven by 186% product sales growth and expanding global demand for non-lethal solutions.
Bookings reached $3.2 million, with $2.1 million from international sales, reflecting strong global traction.
Secured a key purchase order from the U.S. Department of Homeland Security, marking early federal adoption.
Operational focus on agency-wide adoption, federal market entry, and innovation in drone and counter-drone solutions.
Cash and cash equivalents increased to $7.3 million, supported by a $5.0 million private placement and warrant exercises.
Financial highlights
Product sales surged 186% year-over-year to $0.9 million, driven by BolaWrap 150 demand.
Technology-enabled services revenue fell to $0.2 million, reflecting a shift to higher-margin software and subscriptions.
Gross profit rose 16% to $0.7 million, but gross margin declined to 62% from 78% due to higher hardware mix.
SG&A expenses increased to $5.4 million, primarily due to higher share-based compensation and sales investments.
Cash used in operations improved 59% to $1.2 million.
Outlook and guidance
Management targets approximately 100% revenue growth for 2026, supported by pipeline visibility and Q1 trends.
Focus on converting pipeline, deepening agency adoption, and advancing federal/international opportunities.
Operating losses are expected to continue until sufficient scale and recurring revenue are achieved.
Results will be influenced by government budget cycles, procurement processes, and grant funding availability.
Anticipates expanding into new international markets and verticals such as healthcare.
Latest events from Wrap Technologies
- Targeting 100% revenue growth in 2026, fueled by agency-wide deployments and recurring revenue.WRAP
Q4 202526 Mar 2026 - Registering 5M shares for resale post-private placement, with potential for significant dilution.WRAP
Registration Filing9 Feb 2026 - Q3 2025 revenue up 241% to $2.0M, with 59% margin and rising recurring sales.WRAP
Q3 20253 Feb 2026 - Margins up, losses down, and new offerings drive growth amid global expansion plans.WRAP
Q4 202424 Dec 2025 - 6 million shares registered for resale may dilute shareholders by 10%, supporting corporate needs.WRAP
Registration Filing16 Dec 2025 - Registration of 6 million shares for resale may cause significant dilution and market impact.WRAP
Registration Filing16 Dec 2025 - Shelf registration enables up to $200M in securities for public safety tech expansion.WRAP
Registration Filing16 Dec 2025 - Annual meeting to vote on directors, auditor, equity plan expansion, and governance matters.WRAP
Proxy Filing1 Dec 2025 - Resale registration of 6.4M shares may cause dilution; warrant proceeds fund general operations.WRAP
Registration Filing29 Nov 2025